OrbusNeich, a company based in Hong Kong, is releasing in the U.S., following FDA clearance, its Sapphire II PRO and the Sapphire NC Plus PTCA balloon dilation catheters. Both devices are indicated for dilation of coronary artery or bypass graft stenoses in cases of ischemia, and for opening up coronary artery occlusions following an infarct. The (Read more...)